An investigation was conducted to determine the impact of trifluoroacetic-acid (76051) (TFA) on the growth, protein synthesis, and glycosylation of a murine glioma cell, C6, in-vitro. One day exposure to TFA caused a slight concentration dependent enhancement of cell growth. At 8.38 millimolar (mM) a 28% increase was noted. Exposure for 1 to 5 days caused an increase in leucine incorporation into C6 cells. The high dose of TFA (10mM) suppressed the intracellular ATP, GTP, and CTP pool. At lower concentrations, TFA elevated ATP levels 11 to 15% while it exerted no influence on UTP or CTP. Intracellular GTP concentration declined in a dose dependent fashion. One day exposure at 5mM reduced the rate of mannose incorporation into glycoproteins and dolichol linked oligosaccharide to 71 and 39% of control levels, respectively. Five days exposure caused further decline in mannose incorporation and caused an additional effect on the dolichol linked oligosaccharides. No significant decline in glucosamine incorporation in glycoprotein and dolichol linked oligosaccharide was observed. Treatment for 24 hours with 5 and 15mM TFA accelerated lectin induced agglutination. The observed loss of terminal sialyl residues in TFA treated cells could cause an increase in the amount of terminally exposed galactose residues. Such surfaces bind more readily to RCA, and the cells thus become more sensitive to the treatment of this particular lectin.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.